The industry-funded National Precursor Log Exchange for tracking pseudoephedrine product sales is helping cool state lawmakers’ interest in requiring prescriptions for sales of all PSE-containing drugs, says the Consumer Healthcare Products Association.
NPLEx Brings A ‘Quiet’ Year On State PSE Legislation – CHPA
CHPA President and CEO Scott Melville says 2015 is the “quietest” in five years for state legislation on the sale of pseudoephedrine, a testament to NPLEx. Bills for Rx-only PSE sales introduced in four states this year failed.